YAN Jiaqi, WANG Siqi, WANG Zheng, LI Jun. Coptis alkaloids improve gluconeogenesis and lipid accumulation in mouse primary hepatocytes[J]. Basic & Clinical Medicine, 2023, 43(6): 923-930.
Huang TD, Behary J, Zekry A. Non-alcoholic fatty liver disease: a review of epidemiology, risk factors, diagnosis and management[J]. Intern Med J, 2020, 50:1038-1047.
[3]
Qu X, Guan P, Xu L, et al. Riligustilide alleviates hepatic insulin resistance and gluconeogenesis in T2DM mice through multitarget actions[J]. Phytother Res, 2022, 36:462-474.
[4]
Adeshirlarijaney A, Gewirtz AT. Considering gut micro-biota in treatment of type 2 diabetes mellitus[J]. Gut Microbes, 2020, 11:253-264.
[5]
Ye Y, Han C, Li Y, et al. Berberine alleviates type 2 diabetic symptoms by altering gut microbiota and reducing aromatic amino acids[J]. Biomed Pharmacother, 2020, 131:842-846.
[6]
Xiao S, Liu C, Chen M, et al. Scutellariae radix and coptidis rhizoma ameliorate glycolipid metabolism of type 2 diabetic rats by modulating gut microbiota and its metabolites[J]. Appl Microbiol Biotechnol, 2020, 104:303-317
[7]
Pang B, Yu X, Zhou Q, et al. Effect of Rhizoma coptidis on treating diabetes mellitus[J]. Evid Based Complement Altern Med, 2015, 205: 839-846.